The role of kindlins in cell biology and relevance to human disease

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 5, 2010, Pages 595-603

  Lai Cheong, J E ^a   Parsons, M ^b   McGrath, J A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Actin; Focal adhesion; Integrins; Kindler syndrome; Kindlin

Indexed keywords

EZRIN; INTEGRIN; KINDLIN; KINDLIN 1; KINDLIN 2; KINDLIN 3; MEMBRANE PROTEIN; MOESIN; PLECKSTRIN; RADIXIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; CHROMOSOME 11Q; CHROMOSOME 14Q; CHROMOSOME 20P; CYTOLOGY; FOCAL ADHESION; HUMAN; LEUKOCYTE ADHESION DEFICIENCY; LOSS OF FUNCTION MUTATION; NONHUMAN; PATHOGENESIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW;

ANIMALS; CARRIER PROTEINS; CYTOSKELETAL PROTEINS; FOCAL ADHESIONS; GENETIC DISEASES, INBORN; HUMANS; INTEGRINS; MEMBRANE PROTEINS; MUSCLE PROTEINS; NEOPLASM PROTEINS; NEOPLASMS; PROTEIN ISOFORMS; SYNDROME;

EID: 77649181584     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2009.10.015     Document Type: Review

References (80)

1. Adair B.D., Xiong J.P., Maddock C., Goodman S.L., Arnaout M.A., and Yeager M. Three-dimensional EM structure of the ectodomain of integrin {alpha}V{beta}3 in a complex with fibronectin. J Cell Biol 168 (2005) 1109-1118
2. Akazawa H., Kudoh S., Mochizuki N., Takekoshi N., Takano H., Nagai T., et al. A novel LIM protein Cal promotes cardiac differentiation by association with CSX/NKX2-5. J Cell Biol 164 (2004) 395-405
3. Andreasen P.A., Kjoller L., Christensen L., and Duffy M.J. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 72 (1997) 1-22
4. Arita K., Wessagowit V., Inamadar A.C., Palit A., Fassihi H., Lai-Cheong J.E., et al. Unusual molecular findings in Kindler syndrome. Br J Dermatol 157 (2007) 1252-1256
5. Ashton G.H. Kindler syndrome. Clin Exp Dermatol 29 (2004) 116-121
6. Ashton G.H., McLean W.H., South A.P., Oyama N., Smith F.J., Al-Suwaid R., et al. Recurrent mutations in kindlin-1, a novel keratinocyte focal contact protein, in the autosomal recessive skin fragility and photosensitivity disorder, Kindler syndrome. J Invest Dermatol 122 (2004) 78-83
7. Askari J.A., Buckley P.A., Mould A.P., and Humphries M.J. Linking integrin conformation to function. J Cell Sci 122 (2009) 165-170
8. Bai J., Binari R., Ni J.Q., Vijayakanthan M., Li H.S., and Perrimon N. RNA interference screening in Drosophila primary cells for genes involved in muscle assembly and maintenance. Development 135 (2008) 1439-1449
9. Calderwood D.A. Integrin activation. J Cell Sci 117 (2004) 657-666
10. Calderwood D.A. Talin controls integrin activation. Biochem Soc Trans 32 (2004) 434-437
11. Calderwood D.A., Yan B., de Pereda J.M., Alvarez B.G., Fujioka Y., Liddington R.C., et al. The phosphotyrosine binding-like domain of talin activates integrins. J Biol Chem 277 (2002) 21749-21758
12. Calderwood D.A., Zent R., Grant R., Rees D.J., Hynes R.O., and Ginsberg M.H. The Talin head domain binds to integrin beta subunit cytoplasmic tails and regulates integrin activation. J Biol Chem 274 (1999) 28071-28074
13. Campbell I.D., and Ginsberg M.H. The talin-tail interaction places integrin activation on FERM ground. Trends Biochem Sci 29 (2004) 429-435
14. Chen J., Salas A., and Springer T.A. Bistable regulation of integrin adhesiveness by a bipolar metal ion cluster. Nat Struct Biol 10 (2003) 995-1001
15. Critchley D.R. Biochemical and structural properties of the integrin-associated cytoskeletal protein talin. Annu Rev Biophys 38 (2009) 235-254
16. Critchley D.R., and Gingras A.R. Talin at a glance. J Cell Sci 121 (2008) 1345-1347
17. Dowling J.J., Gibbs E., Russell M., Goldman D., Minarcik J., Golden J.A., et al. Kindlin-2 is an essential component of intercalated discs and is required for vertebrate cardiac structure and function. Circ Res 102 (2008) 423-431
18. Dowling J.J., Vreede A.P., Kim S., Golden J., and Feldman E.L. Kindlin-2 is required for myocyte elongation and is essential for myogenesis. BMC Cell Biol 9 (2008) 36
19. Duffy M.J. Urokinase-type plasminogen activator: a potent marker of metastatic potential in human cancers. Biochem Soc Trans 30 (2002) 207-210
20. Emanuel P.O., Rudikoff D., and Phelps R.G. Aggressive squamous cell carcinoma in Kindler syndrome. Skinmed 5 (2006) 305-307
21. Garcia-Alvarez B., de Pereda J.M., Calderwood D.A., Ulmer T.S., Critchley D., Campbell I.D., et al. Structural determinants of integrin recognition by talin. Mol Cell 11 (2003) 49-58
22. Gozgit J.M., Pentecost B.T., Marconi S.A., Otis C.N., Wu C., and Arcaro K.F. Use of an aggressive MCF-7 cell line variant, TMX2-28, to study cell invasion in breast cancer. Mol Cancer Res 4 (2006) 905-913
23. Hannigan G.E., Coles J.G., and Dedhar S. Integrin-linked kinase at the heart of cardiac contractility, repair, and disease. Circ Res 100 (2007) 1408-1414
24. Harburger D.S., Bouaouina M., and Calderwood D.A. Kindlin-1 and -2 directly bind the C-terminal region of beta integrin cytoplasmic tails and exert integrin-specific activation effects. J Biol Chem 284 (2009) 11485-11497
25. Has C., Herz C., Zimina E., Qu H.Y., He Y., Zhang Z.G., et al. Kindlin-1 is required for RhoGTPase-mediated lamellipodia formation in keratinocytes. Am J Pathol (2009)
26. Has C., Ludwig R.J., Herz C., Kern J.S., Ussar S., Ochsendorf F.R., et al. C-terminally truncated kindlin-1 leads to abnormal adhesion and migration of keratinocytes. Br J Dermatol (2008)
27. Has C., Wessagowit V., Pascucci M., Baer C., Didona B., Wilhelm C., et al. Molecular basis of Kindler syndrome in Italy: novel and recurrent Alu/Alu recombination, splice site, nonsense, and frameshift mutations in the KIND1 gene. J Invest Dermatol 126 (2006) 1776-1783
28. Has C., Yordanova I., Balabanova M., Kazandjieva J., Herz C., Kohlhase J., et al. A novel large FERMT1 (KIND1) gene deletion in Kindler syndrome. J Dermatol Sci 52 (2008) 209-212
29. Herz C., Aumailley M., Schulte C., Schlotzer-Schrehardt U., Bruckner-Tuderman L., and Has C. Kindlin-1 is a phosphoprotein involved in regulation of polarity, proliferation, and motility of epidermal keratinocytes. J Biol Chem 281 (2006) 36082-36090
30. Hovnanian A., Blanchet-Bardon C., and de Prost Y. Poikiloderma of Theresa Kindler: report of a case with ultrastructural study, and review of the literature. Pediatr Dermatol 6 (1989) 82-90
31. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 110 (2002) 673-687
32. Jobard F., Bouadjar B., Caux F., Hadj-Rabia S., Has C., Matsuda F., et al. Identification of mutations in a new gene encoding a FERM family protein with a pleckstrin homology domain in Kindler syndrome. Hum Mol Genet 12 (2003) 925-935
33. Kato K., Shiozawa T., Mitsushita J., Toda A., Horiuchi A., Nikaido T., et al. Expression of the mitogen-inducible gene-2 (mig-2) is elevated in human uterine leiomyomas but not in leiomyosarcomas. Hum Pathol 35 (2004) 55-60
34. Kern J.S., Herz C., Haan E., Moore D., Nottelmann S., von Lilien T., et al. Chronic colitis due to an epithelial barrier defect: the role of kindlin-1 isoforms. J Pathol 213 (2007) 462-470
35. Kim M., Carman C.V., and Springer T.A. Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins. Science 301 (2003) 1720-1725
36. Kindler T. Congenital poikiloderma with traumatic bulla formation and progressive cutaneous atrophy. Br J Dermatol 66 (1954) 104-111
37. Kloeker S., Major M.B., Calderwood D.A., Ginsberg M.H., Jones D.A., and Beckerle M.C. The Kindler syndrome protein is regulated by transforming growth factor-beta and involved in integrin-mediated adhesion. J Biol Chem 279 (2004) 6824-6833
38. Kruger M., Moser M., Ussar S., Thievessen I., Luber C.A., Forner F., et al. SILAC mouse for quantitative proteomics uncovers kindlin-3 as an essential factor for red blood cell function. Cell 134 (2008) 353-364
39. Kuijpers T.W., van de Vijver E., Weterman M.A., de Boer M., Tool A.T., van den Berg T.K., et al. LAD-1/variant syndrome is caused by mutations in FERMT3. Blood 113 (2009) 4740-4746
40. Lai-Cheong J.E., Liu L., Sethuraman G., Kumar R., Sharma V.K., Reddy S.R., et al. Five new homozygous mutations in the KIND1 gene in Kindler syndrome. J Invest Dermatol 127 (2007) 2268-2270
41. Lai-Cheong J.E., Parsons M., Tanaka A., Ussar S., South A.P., Gomathy S., et al. Loss-of-function FERMT1 mutations in Kindler syndrome implicate a role for fermitin family homolog-1 in integrin activation. Am J Pathol (2009)
42. Lai-Cheong J.E., Tanaka A., Hawche G., Emanuel P., Maari C., Taskesen M., et al. Kindler syndrome: a focal adhesion genodermatosis. Br J Dermatol 160 (2009) 233-242
43. Lai-Cheong J.E., Ussar S., Arita K., Hart I.R., and McGrath J.A. Colocalization of kindlin-1, kindlin-2, and migfilin at keratinocyte focal adhesion and relevance to the pathophysiology of Kindler syndrome. J Invest Dermatol 128 (2008) 2156-2165
44. Larjava H., Plow E.F., and Wu C. Kindlins: essential regulators of integrin signalling and cell-matrix adhesion. EMBO Rep 9 (2008) 1203-1208
45. Ley K., Laudanna C., Cybulsky M.I., and Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 7 (2007) 678-689
46. Lotem M., Raben M., Zeltser R., Landau M., Sela M., Wygoda M., et al. Kindler syndrome complicated by squamous cell carcinoma of the hard palate: successful treatment with high-dose radiation therapy and granulocyte-macrophage colony-stimulating factor. Br J Dermatol 144 (2001) 1284-1286
47. Mackinnon A.C., Qadota H., Norman K.R., Moerman D.G., and Williams B.D. C. elegans PAT-4/ILK functions as an adaptor protein within integrin adhesion complexes. Curr Biol 12 (2002) 787-797
48. Malinin N.L., Zhang L., Choi J., Ciocea A., Razorenova O., Ma Y.Q., et al. A point mutation in KINDLIN3 ablates activation of three integrin subfamilies in humans. Nat Med 15 (2009) 313-318
49. McElhinney D.B., Geiger E., Blinder J., Benson D.W., and Goldmuntz E. NKX2.5 mutations in patients with congenital heart disease. J Am Coll Cardiol 42 (2003) 1650-1655
50. Montanez E., Ussar S., Schifferer M., Bosl M., Zent R., Moser M., et al. Kindlin-2 controls bidirectional signaling of integrins. Genes Dev 22 (2008) 1325-1330
51. Mory A., Feigelson S.W., Yarali N., Kilic S.S., Bayhan G.I., Gershoni-Baruch R., et al. Kindlin-3: a new gene involved in the pathogenesis of LAD-III. Blood 112 (2008) 2591
52. Moser M., Bauer M., Schmid S., Ruppert R., Schmidt S., Sixt M., et al. Kindlin-3 is required for beta2 integrin-mediated leukocyte adhesion to endothelial cells. Nat Med 15 (2009) 300-305
53. Moser M., Legate K.R., Zent R., and Fassler R. The tail of integrins, talin, and kindlins. Science 324 (2009) 895-899
54. Moser M., Nieswandt B., Ussar S., Pozgajova M., and Fassler R. Kindlin-3 is essential for integrin activation and platelet aggregation. Nat Med 14 (2008) 325-330
55. Nieswandt B., Moser M., Pleines I., Varga-Szabo D., Monkley S., Critchley D., et al. Loss of talin1 in platelets abrogates integrin activation, platelet aggregation, and thrombus formation in vitro and in vivo. J Exp Med 204 (2007) 3113-3118
56. Pasini E.M., Kirkegaard M., Mortensen P., Lutz H.U., Thomas A.W., and Mann M. In-depth analysis of the membrane and cytosolic proteome of red blood cells. Blood 108 (2006) 791-801
57. Pasvolsky R., Feigelson S.W., Kilic S.S., Simon A.J., Tal-Lapidot G., Grabovsky V., et al. A LAD-III syndrome is associated with defective expression of the Rap-1 activator CalDAG-GEFI in lymphocytes, neutrophils, and platelets. J Exp Med 204 (2007) 1571-1582
58. Pearson M.A., Reczek D., Bretscher A., and Karplus P.A. Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain. Cell 101 (2000) 259-270
59. Petrich B.G., Fogelstrand P., Partridge A.W., Yousefi N., Ablooglu A.J., Shattil S.J., et al. The antithrombotic potential of selective blockade of talin-dependent integrin alpha IIb beta 3 (platelet GPIIb-IIIa) activation. J Clin Invest 117 (2007) 2250-2259
60. Petrich B.G., Marchese P., Ruggeri Z.M., Spiess S., Weichert R.A., Ye F., et al. Talin is required for integrin-mediated platelet function in hemostasis and thrombosis. J Exp Med 204 (2007) 3103-3111
61. Pfaff M., Liu S., Erle D.J., and Ginsberg M.H. Integrin beta cytoplasmic domains differentially bind to cytoskeletal proteins. J Biol Chem 273 (1998) 6104-6109
62. Rogalski T.M., Mullen G.P., Gilbert M.M., Williams B.D., and Moerman D.G. The UNC-112 gene in Caenorhabditis elegans encodes a novel component of cell-matrix adhesion structures required for integrin localization in the muscle cell membrane. J Cell Biol 150 (2000) 253-264
63. Ross D.T., Scherf U., Eisen M.B., Perou C.M., Rees C., Spellman P., et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 24 (2000) 227-235
64. Sadler E., Klausegger A., Muss W., Deinsberger U., Pohla-Gubo G., Laimer M., et al. Novel KIND1 gene mutation in Kindler syndrome with severe gastrointestinal tract involvement. Arch Dermatol 142 (2006) 1619-1624
65. Shi X., Ma Y.Q., Tu Y., Chen K., Wu S., Fukuda K., et al. The MIG-2/integrin interaction strengthens cell-matrix adhesion and modulates cell motility. J Biol Chem 282 (2007) 20455-20466
66. Shi X., and Wu C. A suppressive role of mitogen inducible gene-2 in mesenchymal cancer cell invasion. Mol Cancer Res 6 (2008) 715-724
67. Shimizu H., Sato M., Ban M., Kitajima Y., Ishizaki S., Harada T., et al. Immunohistochemical, ultrastructural, and molecular features of Kindler syndrome distinguish it from dystrophic epidermolysis bullosa. Arch Dermatol 133 (1997) 1111-1117
68. Siegel D.H., Ashton G.H., Penagos H.G., Lee J.V., Feiler H.S., Wilhelmsen K.C., et al. Loss of kindlin-1, a human homolog of the Caenorhabditis elegans actin-extracellular-matrix linker protein UNC-112, causes Kindler syndrome. Am J Hum Genet 73 (2003) 174-187
69. Su A.I., Welsh J.B., Sapinoso L.M., Kern S.G., Dimitrov P., Lapp H., et al. Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res 61 (2001) 7388-7393
70. Svensson L., Howarth K., McDowall A., Patzak I., Evans R., Ussar S., et al. Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation. Nat Med 15 (2009) 306-312
71. Tu Y., Wu S., Shi X., Chen K., and Wu C. Migfilin and Mig-2 link focal adhesions to filamin and the actin cytoskeleton and function in cell shape modulation. Cell 113 (2003) 37-47
72. Ussar S., Moser M., Widmaier M., Rognoni E., Harrer C., Genzel-Boroviczeny O., et al. Loss of Kindlin-1 causes skin atrophy and lethal neonatal intestinal epithelial dysfunction. PLoS Genet 4 (2008) e1000289
73. Ussar S., Wang H.V., Linder S., Fassler R., and Moser M. The Kindlins: subcellular localization and expression during murine development. Exp Cell Res 312 (2006) 3142-3151
74. Vinogradova O., Vaynberg J., Kong X., Haas T.A., Plow E.F., and Qin J. Membrane-mediated structural transitions at the cytoplasmic face during integrin activation. Proc Natl Acad Sci USA 101 (2004) 4094-4099
75. Vinogradova O., Velyvis A., Velyviene A., Hu B., Haas T., Plow E., et al. A structural mechanism of integrin alpha(IIb)beta(3) "inside-out" activation as regulated by its cytoplasmic face. Cell 110 (2002) 587-597
76. Wegener K.L., Partridge A.W., Han J., Pickford A.R., Liddington R.C., Ginsberg M.H., et al. Structural basis of integrin activation by talin. Cell 128 (2007) 171-182
77. Weinstein E.J., Bourner M., Head R., Zakeri H., Bauer C., and Mazzarella R. URP1: a member of a novel family of PH and FERM domain-containing membrane-associated proteins is significantly over-expressed in lung and colon carcinomas. Biochim Biophys Acta 1637 (2003) 207-216
78. Wiebe C.B., Petricca G., Hakkinen L., Jiang G., Wu C., and Larjava H.S. Kindler syndrome and periodontal disease: review of the literature and a 12-year follow-up case. J Periodontol 79 (2008) 961-966
79. Wu C. Migfilin and its binding partners: from cell biology to human diseases. J Cell Sci 118 (2005) 659-664
80. Zhou C., Song S., and Zhang J. A novel 3017-bp deletion mutation in the FERMT1 (KIND1) gene in a Chinese family with Kindler syndrome. Br J Dermatol 160 (2009) 1119-1122